Supreme Court temporarily extends women’s access to a widely used abortion pill
Summary
The U.S. Supreme Court has temporarily allowed women to keep accessing the abortion pill mifepristone without restrictions until at least Thursday, as it reviews a legal challenge to the drug's rules. This case involves Louisiana’s effort to limit how mifepristone is prescribed, claiming the drug is unsafe and conflicts with state abortion laws.Key Facts
- The Supreme Court's order stops a federal appeals court’s restrictions on mifepristone from taking effect for now.
- Women can still get the pill by pharmacy or mail without needing an in-person doctor visit.
- Louisiana filed a lawsuit aimed at rolling back FDA rules on prescribing mifepristone.
- Mifepristone, approved in 2000, has been declared safe and effective by FDA experts many times.
- Medication abortions made up nearly two-thirds of abortions in the U.S. in 2023.
- The Supreme Court previously blocked attempts to restrict the pill after Roe v. Wade was overturned.
- Medical groups and drug companies warn that limiting the pill could disrupt drug approvals.
- President Donald Trump’s administration has not taken a public stance in this Supreme Court case.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.